| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a86ec4321b3682fe1b78890265532da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886629b0204917254b2bddae0f26b19b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89905f5ee118c520494296c8befeea67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02454b1dae163745b8ce9433a2e0e991
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3bccb0957bf6c669dab6eab8258c8ad |
| publicationDate |
2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UA-114412-C2 |
| titleOfInvention |
SOLID DOSAGE FORM OF HYPURATE (S) -2-AMINO-3- (4- (2-AMINO-6 - ((R) -1- (4-CHLORO-2- (3-METHYL-1H-PYRAZOL-1-IL) ) PHENYL) -2,2,2-TRIFLORETOXES) PYRIMIDIN-4-yl) PHENYL) PROPANOATE |
| abstract |
The invention relates to a solid pharmaceutical dosage form containing (S) -ethyl 2-amino-3- (4- (2-amino-6 - ((R) -1- (4-chloro-2- (3-methyl- 1H-pyrazol-1-yl) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-yl) phenyl) propanoate. |
| priorityDate |
2011-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |